Clinical Trial Update: Effect of Aclidinium/Formoterol on Nighttime Lung Function and Morning Symptoms in Chronic Obstructive Pulmonary Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating aclidinium/formoterol on nighttime lung function and morning symptoms in COPD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• aclidinium/formoterol

Snippet

Sponsor: Queen's University | Conditions: COPD | Phase 4 | Status: COMPLETED